- Sampo’s net income for the second quarter was EUR 417 million, surpassing the estimated EUR 343.4 million.
- The company achieved an underwriting profit of EUR 393 million.
- Pretax profit reached EUR 526 million, exceeding the estimate of EUR 438.3 million.
- Earnings per share (EPS) were recorded at EUR 0.16.
- Sampo’s combined ratio stood at 82.6%, slightly above the forecast of 81.9%.
- Analyst recommendations include 11 buys, 9 holds, and 2 sells for Sampo’s stock.
A look at Sampo Oyj Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts examining the long-term outlook for Sampo Oyj, an insurance brokerage firm, have assessed the company using Smartkarma Smart Scores. With a solid score in Resilience and Momentum, Sampo Oyj appears well-positioned for stability and potential growth in the future. While the Value, Dividend, and Growth scores are moderate, the higher ratings in Resilience and Momentum indicate a favorable overall outlook for the company’s future prospects. Sampo Oyj provides a range of insurance products to customers globally, which could contribute to its sustained performance in the long run.
Considering the Smart Scores assessment, Sampo Oyj seems to have a promising long-term outlook, supported by strong Resilience and Momentum indicators. Although the Value, Dividend, and Growth scores are average, the company’s global presence and diverse insurance offerings are factors that could drive future success. Investors monitoring Sampo Oyj may find the combination of stability and growth potential indicated by the Smart Scores encouraging for their investment decisions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
